Smartphone-based respiratory diagnostic maker, ResApp Health (ASX:RAP), plunged by almost 30% after announcing its cough app might need a bit of fine tuning.Read MoreThe Australian
Shares crash as smartphone Covid tool falls short
Posted by Posted by